Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease.
Erichsen K, Hausken T, Ulvik RJ, Svardal A, Berstad A, Berge RK
Scand J Gastroenterol 2003;38(5):543-548.
NATA Rating :
Review by :
There are a few who disregard the importance of free oxygen radicals as a cause of tissue injury and of DNA damage in inflammatory bowel diseases (potentially leading to the development of colorectal cancer). There are also a few who disbelieve in the intolerance of oral ferrous iron in inflammatory bowel diseases. As Erichsen and coworkers have created a link between intolerability and pro-oxidant activity of oral ferrous fumarate in Crohn’s disease, they provide important information for clinical practice, i.e. not to use oral iron in inflammatory bowel diseases.
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.